These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6710729)

  • 1. In vivo mapping of bladder cancer (chromocystoscopy for in vivo detection of neoplastic urothelial surfaces).
    Gill WB; Strauss FH
    Urology; 1984 Apr; 23(4 Suppl):63-6. PubMed ID: 6710729
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo detection by microscopic chromocystoscopy of concurrent urothelial atypia in superficial bladder cancer.
    Iguchi A; Kinoshita N; Masaki Z
    Br J Urol; 1992 Aug; 70(2):152-5. PubMed ID: 1393438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo urothelial surface histology by microscopic chromocystoscopy.
    Gill WB; Huffman JL; Lyon ES; Bagley DH
    J Urol; 1983 Oct; 130(4):669-71. PubMed ID: 6887395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and sensitive method for detection of urinary bladder tumors in rodents.
    Feng Y; Rustan TD; Fretland AJ; Cooley AM; Lee KJ; Becker WK; Hein DW
    Proc West Pharmacol Soc; 1998; 41():11-3. PubMed ID: 9836226
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical value of fluorescence cystoscopy in the detection of superficial transitional epithelial cell carcinoma of the bladder].
    Jichlinski P; Wagniéres G; Forrer M; Mizeret J; Guillou L; Schmidlin F; Graber P; Van den Bergh H; Leisinger HJ
    Ann Urol (Paris); 1997; 31(1):43-8. PubMed ID: 9157821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of clinically occult bladder cancer by in vivo staining with methylene blue.
    Mufti GR; Shah PJ; Parkinson MC; Riddle PR
    Br J Urol; 1990 Feb; 65(2):173-5. PubMed ID: 1690584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.
    Benson RC
    Prog Clin Biol Res; 1984; 170():795-804. PubMed ID: 6241716
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved detection of nonmuscle invasive urothelial carcinoma of the bladder using pirarubicin endoscopy: a prospective, single-center preliminary study.
    Han J; Lin T; Xu K; Jiang C; Huang H; Yin X; Xie W; Yao Y; Zhang C; Huang J
    J Endourol; 2010 Nov; 24(11):1801-6. PubMed ID: 20932082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification.
    Gill WB; Huffman JL; Lyon ES; Bagley DH; Schoenberg HW; Straus FH
    Cancer; 1984 Jun; 53(12):2724-7. PubMed ID: 6202385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical diagnosis of bladder cancer by microscopic chromocystoscopy].
    Iguchi A
    Nihon Hinyokika Gakkai Zasshi; 1988 Dec; 79(12):1928-36. PubMed ID: 2466141
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and localization of In situ carcinoma of the bladder with hematoporphyrin derivative.
    Benson RC; Farrow GM; Kinsey JH; Cortese DA; Zincke H; Utz DC
    Mayo Clin Proc; 1982 Sep; 57(9):548-55. PubMed ID: 7109683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evans blue as a selective dye marker for white-light diagnosis of non-muscle-invasive bladder cancer: an in vitro study.
    Roelants M; Huygens A; Crnolatac I; Van Cleynenbreugel B; Lerut E; Van Poppel H; de Witte PA
    BJU Int; 2012 Jan; 109(2):300-5. PubMed ID: 21854534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic evaluation of transitional cell carcinoma of the bladder.
    Kern WH; Bales CE; Webster WW
    J Urol; 1968 Nov; 100(5):616-22. PubMed ID: 5682536
    [No Abstract]   [Full Text] [Related]  

  • 16. Transitional cell carcinoma of the bladder in a young adult.
    Khan SA; Srinivas V
    Urol Int; 1985; 40(4):238-9. PubMed ID: 4049583
    [No Abstract]   [Full Text] [Related]  

  • 17. The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma.
    Ordon M; Boerner S; Zlotta AR; Jewett MA; Fleshner N
    BJU Int; 2009 Dec; 104(11):1641-5. PubMed ID: 19583723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reliability of urinary cytology for follow-up of bladder cancer].
    Ginesin Y; Malberger E; Semberg S; Levin DR
    Harefuah; 1987 Sep; 113(5-6):101-3. PubMed ID: 3692366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder].
    Tschirdewahn S; Vom Dorp F
    Urologe A; 2015 Apr; 54(4):480-3. PubMed ID: 25784270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence cystoscopy.
    Vallancien G; Richard F; Haertig A; Mathieu F; Kuss R
    Prog Clin Biol Res; 1984; 162A():327-30. PubMed ID: 6483915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.